Remap Consulting is a specialist pharmaceutical pricing and market access consultancy

We work with people responsible for the pricing and reimbursement of products who are asking:

What is the optimal price for our product?
Have we got the right evidence to support pricing and market access at launch?
Do we have the right training capabilities in house to secure pricing and reimbursement?
What is the pricing and market access potential for our business development opportunities?

Launch and strategy implementation icon


Learn More >

Price and market access training

Price & Market Access Training

Learn More >

Price optimization strategy


Learn More >

We now offer the NICE META tool as part of our Launch service   

Click here to find out more >

Our mission is to support you in solving your pricing and market access challenges to improve patient access to your products

Latest News

One lung cancer drug receives NHS England approval, while another is rejected

July 8th, 2019|

Article courtesy of Cancer Research UK. A targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision drug, for the [...]

Joint pricing and health technology assessment between European countries: is this the future of pricing and market access negotiations?

June 27th, 2019|

Since 2015 there has been substantial growth in the number of multi-country collaborations across Europe, driven primarily by the increasing [...]